Relationship between Escherichia coli and colon cancer

Authors

  • A Al-Harbi Shoroug Jeddah University, Faculty of Science, Department of Biological Sciences-Microbiology Section, Saudi Arabia, P.O. Box: 13520, Jeddah 21414, Saudi Arabia.
  • A. Al-Judaibi Awatif Jeddah University, Faculty of Science, Department of Biological Sciences-Microbiology Section, Saudi Arabia, P.O. Box: 13520, Jeddah 21414, Saudi Arabia.

DOI:

https://doi.org/10.30574/gscbps.2020.12.2.0101

Keywords:

Colon cancer, E. coli- bioactivity, Adhesion- invasion

Abstract

Microbiota in the intestine provides major benefits to human health. The development of these microbiota depends on the individual's diet and lifestyle and is reflected in the impact of the microbiota on the body's energy and metabolism. In a normal healthy environment, Escherichia coli grows healthy and reflecting in the human body's metabolism. However, it has been known that there is linking the community of bacterial structure factors of the intestinal microbiota to colorectal cancer development and progression, E. coli can infect and cause changes in the gut that can finally lead to cellular transformation. Thus, chronic inflammation induced by E. coli during inflammatory bowel disease predisposes an individual to colorectal cancer. E. coli is a type species of the genus Escherichia. E. coli is a Gram-negative bacillus, facultative anaerobe, motile. E. coli producing many of toxin such as colibactin is a hybrid nonribosomal peptide-polyketide encoded by polyketide synthase (pks) can induce DNA double-strand breaks leading to chromosomal aberrations and increases the frequency of gene mutations and able to induce senescence-associated secretome to contribute to colon cancer development. Therefore, the study aims to investigate the bioactivity of E. coli on colon cell that has transformed to a cancer cell and to understand the E. coli as microbiota behavior in a certain environment the effect of this new environment on its activities.

Metrics

Metrics Loading ...

References

Conway T and Cohen PS. (2015). Commensal and pathogenic Escherichia coli metabolism in the gut. Metabolism and bacterial pathogenesis, 343-362.

Gaston JSH. (2017). Recent advances in understanding spondyloarthritis. F1000Research, 6.

Jang J, Hur HG, Sadowsky MJ, Byappanahalli MN, Yan T and Ishii S. (2017). Environmental Escherichia coli: ecology and public health implications—a review. Journal of applied microbiology, 123(3), 570-581.

Kaper JB, Nataro JP and Mobley HL. (2004). Pathogenic escherichia coli. Nature reviews microbiology, 2(2), 123-140.

Nataro JP and Kaper JB. (1998). Diarrheagenic escherichia coli. Clinical microbiology reviews, 11(1), 142-201.

Camprubí-Font C, Ewers C, Lopez-Siles M and Martinez-Medina M. (2019). Genetic and phenotypic features to screen for putative Adherent-Invasive Escherichia coli. Frontiers in microbiology, 10, 108.

Gomes TA, Elias WP, Scaletsky IC, Guth BE, Rodrigues JF, Piazza RM and Martinez MB. (2016). Diarrheagenic Escherichia coli. brazilian journal of microbiology, 47, 3-30.

Jubelin G, Desvaux M, Schüller S, Etienne-Mesmin L, Muniesa M and Blanquet-Diot S. (2018). Modulation of enterohaemorrhagic Escherichia coli survival and virulence in the human gastrointestinal tract. Microorganisms, 6(4), 115.

Mirsepasi-Lauridsen HC, Vallance BA, Krogfelt KA and Petersen AM. (2019). Escherichia coli pathobionts associated with inflammatory bowel disease. Clinical microbiology reviews, 32(2), e00060-18.

Pasqua M, Michelacci V, Di Martino ML, Tozzoli R, Grossi M, Colonna B and Prosseda G. (2017). The intriguing evolutionary journey of enteroinvasive E. coli (EIEC) toward pathogenicity. Frontiers in microbiology, 8, 2390.

Thakur N, Jain S, Changotra H, Shrivastava R, Kumar Y, Grover N and Vashistt J. (2018). Molecular characterization of diarrheagenic Escherichia coli pathotypes: Association of virulent genes, serogroups, and antibiotic resistance among moderate‐to‐severe diarrhea patients. Journal of clinical laboratory analysis, 32(5), e22388.

Wang H, Zhong Z, Luo Y, Cox E and Devriendt B. (2019). Heat-stable enterotoxins of enterotoxigenic Escherichia coli and their impact on host immunity. Toxins, 11(1), 24.

Zhang YJ, Li S, Gan RY, Zhou T, Xu DP and Li HB. (2015). Impacts of gut bacteria on human health and diseases. International journal of molecular sciences, 16(4), 7493-7519.

Chen W, Liu F, Ling Z, Tong X and Xiang C. (2012). Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PloS one, 7(6).

Koliarakis I, Psaroulaki A, Nikolouzakis TK, Kokkinakis M, Sgantzos MN, Goulielmos G and Tsiaoussis J. (2018). Intestinal microbiota and colorectal cancer: A new aspect of research. J BUON, 23, 1216-1234.

Browne HP, Neville BA, Forster SC and Lawley TD. (2017). Transmission of the gut microbiota: spreading of health. Nature Reviews Microbiology, 15(9), 531.

Katouli M. (2010). Population structure of gut Escherichia coli and its role in development of extra-intestinal infections. Iranian journal of microbiology, 2(2), 59.

O'Hara AM and Shanahan F. (2006). The gut flora as a forgotten organ. EMBO reports, 7(7), 688-693.

Rajoka MSR, Shi J, Mehwish HM, Zhu J, Li Q, Shao D and Yang H. (2017). Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health. Food Science and Human Wellness, 6(3), 121-130.

Raskov H, Burcharth J and Pommergaard HC. (2017). Linking gut microbiota to colorectal cancer. Journal of cancer, 8(17), 3378.

Rosenberg E and Zilber-Rosenberg I. (2016). Do microbiotas warm their hosts? Gut microbes, 7(4), 283-285.

Rowland IR. (2009). The role of the gastrointestinal microbiota in colorectal cancer. Current pharmaceutical design, 15(13), 1524-1527.

Kline KA, Fälker S, Dahlberg S, Normark S and Henriques-Normark B. (2009). Bacterial adhesins in host-microbe interactions. Cell host & microbe, 5(6), 580-592.

Servin AL. (2014). Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges. Clinical microbiology reviews, 27(4), 823-869.

Juge N. (2012). Microbial adhesins to gastrointestinal mucus. Trends in microbiology, 20(1), 30-39.

Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E and Bray F. (2017). Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study. The Lancet Oncology, 18(12), 1579-1589.

GBD. (2015). Eastern Mediterranean Region Cancer Collaborators. (2018). Burden of cancer in the Eastern Mediterranean Region, 2005–2015: findings from the Global Burden of Disease 2015 Study. International Journal of Public Health, 63(1), 151-164.

Hold GL. (2016). Gastrointestinal microbiota and colon cancer. Digestive diseases, 34(3), 244-250.

Mosli MH and Al-Ahwal MS. (2012). Colorectal cancer in the Kingdom of Saudi Arabia: need for screening. Asian pacific journal of cancer prevention, 13(8), 3809-3813.

Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J and Lochs H. (1998). Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology, 115(2), 281-286.

Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E and Bonnet M. (2016). Gut microbiota imbalance and colorectal cancer. World Journal of Gastroenterology, 22(2), 501.

Veziant J, Gagnière J, Jouberton E, Bonnin V, Sauvanet P, Pezet D and Bonnet M. (2016). Association of colorectal cancer with pathogenic Escherichia coli: Focus on mechanisms using optical imaging. World journal of clinical oncology, 7(3), 293.

Raisch J, Buc E, Bonnet M, Sauvanet P, Vazeille E, De Vallée A and Bringer MA. (2014). Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World Journal of Gastroenterology: WJG, 20(21), 6560.

O'keefe SJ. (2016). Diet, microorganisms and their metabolites, and colon cancer. Nature reviews Gastroenterology & hepatology, 13(12), 691.

Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault ML, Van Nhieu JT and Delchier JC. (2013). Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Therapeutic advances in gastroenterology, 6(3), 215-229.

Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A and Bonnet R. (2013). High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PloS one, 8(2).

Coleman OI and Nunes T. (2016). Role of the microbiota in colorectal cancer: updates on microbial associations and therapeutic implications. BioResearch open access, 5(1), 279-288.

Hernández-Luna MA, Lagunes-Servin HE and Lopez-Briones S. (2016). The role of Escherichia coli in the development and progression of cancer. ARC Journal of Cancer Science, 3(1), 1-11.

Ohtani N. (2015). Microbiome and cancer. In Seminars in immunopathology Springer Berlin Heidelberg, 37(1), 65-72.

Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B and Darfeuille-Michaud A. (2014). Colonization of the human gut by E. coli and colorectal cancer risk. Clinical Cancer Research, 20(4), 859-867.

Iyadorai T, Mariappan V, Vellasamy KM, Wanyiri JW, Roslani AC, Lee GK and Vadivelu J. (2020). Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia. PloS one, 15(1), e0228217.

Dai Z, Zhang J, Wu Q, Chen J, Liu J, Wang L and Li Z. (2019). The role of microbiota in the development of colorectal cancer. International journal of cancer, 145(8), 2032-2041.

Lin C, Cai X, Zhang J, Wang W, Sheng Q, Hua H and Zhou X. (2019). Role of gut microbiota in the development and treatment of colorectal cancer. Digestion, 100(1), 62-68.

Sears CL and Garrett WS. (2014). Microbes, microbiota, and colon cancer. Cell host & microbe, 15(3), 317-328.

Touchon M, Hoede C, Tenaillon O, Barbe V, Baeriswyl S, Bidet, P and Calteau A. (2009). Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS genetics, 5(1).

Wassenaar TM. (2018). E. coli and colorectal cancer: a complex relationship that deserves a critical mindset. Critical reviews in microbiology, 44(5), 619-632.

Leung A, Tsoi H and Yu J. (2015). Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening. Expert review of gastroenterology & hepatology, 9(5), 651-657.

Gagnière J, Bonnin V, Jarrousse AS, Cardamone E, Agus A, Uhrhammer N and Pezet D. (2017). Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer. Clinical Science, 131(6), 471-485.

Zou S, Fang L and Lee MH. (2018). Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterology report, 6(1), 1-12.

Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L and Pezet D. (2014). Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut, 63(12), 1932-1942.

Downloads

Published

2022-02-04

How to Cite

Shoroug , A. A.-H., & Awatif , A. A.-J. (2022). Relationship between Escherichia coli and colon cancer. GSC Biological and Pharmaceutical Sciences, 12(2), 188–193. https://doi.org/10.30574/gscbps.2020.12.2.0101

Issue

Section

Review Article